FI882926A0 - Cykliska peptolider. - Google Patents

Cykliska peptolider.

Info

Publication number
FI882926A0
FI882926A0 FI882926A FI882926A FI882926A0 FI 882926 A0 FI882926 A0 FI 882926A0 FI 882926 A FI882926 A FI 882926A FI 882926 A FI882926 A FI 882926A FI 882926 A0 FI882926 A0 FI 882926A0
Authority
FI
Finland
Prior art keywords
cyclic
peptolider
peptolides
cyclic peptolides
undecapeptide
Prior art date
Application number
FI882926A
Other languages
English (en)
Other versions
FI87928B (fi
FI882926A (fi
FI87928C (fi
Inventor
Michael Morris Dreyfuss
Max H Schreier
Hans Tscherter
Roland Wenger
Original Assignee
Sandoz Ag
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Sandoz Ag filed Critical Sandoz Ag
Publication of FI882926A0 publication Critical patent/FI882926A0/fi
Publication of FI882926A publication Critical patent/FI882926A/fi
Publication of FI87928B publication Critical patent/FI87928B/fi
Application granted granted Critical
Publication of FI87928C publication Critical patent/FI87928C/fi

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K11/00Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K11/02Depsipeptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof cyclic, e.g. valinomycins ; Derivatives thereof
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K7/00Peptides having 5 to 20 amino acids in a fully defined sequence; Derivatives thereof
    • C07K7/64Cyclic peptides containing only normal peptide links
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00Drugs for immunological or allergic disorders
    • A61P37/02Immunomodulators
    • A61P37/06Immunosuppressants, e.g. drugs for graft rejection
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/14Fungi; Culture media therefor
    • C12N1/145Fungal isolates
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12RINDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00Microorganisms ; Processes using microorganisms
    • C12R2001/645Fungi ; Processes using fungi
    • YGENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02ATECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Medicinal Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Zoology (AREA)
  • Biotechnology (AREA)
  • Wood Science & Technology (AREA)
  • Biophysics (AREA)
  • Molecular Biology (AREA)
  • Immunology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Virology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Veterinary Medicine (AREA)
  • Botany (AREA)
  • Mycology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Public Health (AREA)
  • Biomedical Technology (AREA)
  • Microbiology (AREA)
  • Transplantation (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Emulsifying, Dispersing, Foam-Producing Or Wetting Agents (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
FI882926A 1987-06-19 1988-06-17 Foerfarande foer framstaellning av cykliska peptolider FI87928C (fi)

Applications Claiming Priority (4)

Application Number Priority Date Filing Date Title
CH231787 1987-06-19
CH231787 1987-06-19
CH251787 1987-07-02
CH251787 1987-07-02

Publications (4)

Publication Number Publication Date
FI882926A0 true FI882926A0 (fi) 1988-06-17
FI882926A FI882926A (fi) 1988-12-20
FI87928B FI87928B (fi) 1992-11-30
FI87928C FI87928C (fi) 1993-03-10

Family

ID=25690129

Family Applications (1)

Application Number Title Priority Date Filing Date
FI882926A FI87928C (fi) 1987-06-19 1988-06-17 Foerfarande foer framstaellning av cykliska peptolider

Country Status (17)

Country Link
US (1) US5116816A (fi)
EP (1) EP0296123B1 (fi)
JP (1) JP2641256B2 (fi)
KR (1) KR970010928B1 (fi)
AT (1) ATE110784T1 (fi)
AU (1) AU623078B2 (fi)
CA (1) CA1338183C (fi)
DE (1) DE3851268T2 (fi)
ES (1) ES2056954T3 (fi)
FI (1) FI87928C (fi)
HU (1) HU204101B (fi)
IE (1) IE64008B1 (fi)
IL (1) IL86789A (fi)
MY (1) MY103735A (fi)
NZ (1) NZ225071A (fi)
PH (1) PH25933A (fi)
PT (1) PT87763B (fi)

Families Citing this family (32)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
HU213553B (en) * 1992-05-25 1997-07-28 Biogal Gyogyszergyar Process for isolating of cyclosporin-a
JP3480848B2 (ja) * 1992-06-19 2003-12-22 タカラバイオ株式会社 環状ペプチドの合成方法
US5260215A (en) * 1992-07-20 1993-11-09 Merck & Co., Inc. Fungal microorganism ATCC 74167 capable of producing cholesterol lowering compounds
US6187547B1 (en) 1993-09-08 2001-02-13 Novartis Ag Assay kit
KR100378974B1 (ko) * 1994-07-27 2003-10-08 노바티스 아게 유기화합물
JP3089350B2 (ja) * 1995-11-20 2000-09-18 ギルフォード ファーマシューティカルズ インコーポレイテッド シクロフィリンロタマーゼ活性の阻害剤
US5858401A (en) * 1996-01-22 1999-01-12 Sidmak Laboratories, Inc. Pharmaceutical composition for cyclosporines
US5709797A (en) * 1996-06-05 1998-01-20 Poli Industria Chimica S.P.A. Method of isolating cyclosporins
CN1130373C (zh) * 1996-09-13 2003-12-10 诺瓦蒂斯有限公司 [3'-脱氧-3'-氧代-MeBmt]'环孢菌素制备方法
US20030220234A1 (en) * 1998-11-02 2003-11-27 Selvaraj Naicker Deuterated cyclosporine analogs and their use as immunodulating agents
DK0991660T3 (da) 1997-10-08 2006-02-13 Isotechnika Inc Deuterede og udeuterede cyclosporinanaloger og deres anvendelse som immunmodulerende midler
EP1214293A1 (en) * 1999-09-08 2002-06-19 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
US6656971B2 (en) 2001-01-25 2003-12-02 Guilford Pharmaceuticals Inc. Trisubstituted carbocyclic cyclophilin binding compounds and their use
US6593362B2 (en) 2001-05-21 2003-07-15 Guilford Pharmaceuticals Inc. Non-peptidic cyclophilin binding compounds and their use
US20040147433A1 (en) * 2001-06-14 2004-07-29 Marcus Keep Neuroimmunophilins for selective neuronal radioprotection
KR100982466B1 (ko) * 2001-10-19 2010-09-16 이소테크니카 인코포레이티드 시클로스포린 유사체의 합성
AR036852A1 (es) * 2001-10-19 2004-10-06 Isotechnika Inc Preconcentrado de una microemulsion de analogos de ciclosporina, su metodo de preparacion y metodos para producir inmunosupresion
WO2004082629A2 (en) * 2003-03-17 2004-09-30 Albany Molecular Research, Inc. Novel cyclosporins
EP1809656A4 (en) * 2004-09-29 2009-03-25 Amr Technology Inc CYCLOSPORINAL KINANALOGA AND ITS PHARMACEUTICAL APPLICATIONS
EP1804823A4 (en) * 2004-09-29 2010-06-09 Amr Technology Inc NEW CYCLOSPORIN ANALOGUE AND ITS PHARMACEUTICAL APPLICATIONS
WO2006041631A2 (en) * 2004-10-06 2006-04-20 Amr Technology, Inc. Novel cyclosporin alkynes and their utility as pharmaceutical agents
ES2314731T3 (es) * 2004-11-22 2009-03-16 Astellas Pharma Inc. Analogo de ciclosporina.
US7696166B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne/alkene analogues for preventing or treating viral-induced disorders
US7696165B2 (en) * 2006-03-28 2010-04-13 Albany Molecular Research, Inc. Use of cyclosporin alkyne analogues for preventing or treating viral-induced disorders
CN102245625A (zh) 2008-10-17 2011-11-16 威斯康星旧生研究基金会 制备有生物活性的α-β肽的方法
CA2741829A1 (en) * 2008-11-06 2010-05-14 Debio Recherche Pharmaceutique S.A. Cycloundecadepsipeptide compounds and use of said compounds as a medicament
DE102008060549A1 (de) 2008-12-04 2010-06-10 MAX-PLANCK-Gesellschaft zur Förderung der Wissenschaften e.V. Wirkstoff-Peptid-Konstrukt zur extrazellulären Anreicherung
WO2011141891A1 (en) 2010-05-12 2011-11-17 Debio Recherche Pharmaceutique S.A. Use of cycloundecadepsipeptide compounds
PT2651965T (pt) 2010-12-15 2019-01-28 Contravir Pharmaceuticals Inc Moléculas analógas de ciclosporinas modificadas ao nivel dos aminoácidos 1 e 3
EP2705856A1 (en) 2012-09-07 2014-03-12 Deutsches Zentrum für Neurodegenerative Erkrankungen e.V. Compounds for the treatment of neurodegenerative disorders
GB201217560D0 (en) * 2012-10-02 2012-11-14 Mitopharm Ltd Novel cyclic depsipeptide compounds and their uses
HUP1500502A2 (en) 2015-10-26 2017-04-28 Rotachrom Tech Kft Process for the purification of cyclosporin-a

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE2819094A1 (de) * 1977-05-10 1978-11-23 Sandoz Ag Cyclosporin-derivate, ihre verwendung und herstellung
JPS5665853A (en) * 1979-11-01 1981-06-03 Sankyo Co Ltd Mycoplanesin derivative and its preparation
EP0056782B1 (en) * 1981-01-09 1984-08-01 Sandoz Ag Novel cyclosporins
US4649047A (en) * 1985-03-19 1987-03-10 University Of Georgia Research Foundation, Inc. Ophthalmic treatment by topical administration of cyclosporin
EP0274873B1 (en) * 1986-12-15 1992-09-23 Eli Lilly And Company Antibiotic a10255 complex and factors, process, microorganisms for its production
GB8727807D0 (en) * 1987-11-27 1987-12-31 Lepetit Spa Novel antibiotic compounds named a/16686 factors a'1,a'2 and a'3

Also Published As

Publication number Publication date
PH25933A (en) 1991-12-19
PT87763B (pt) 1992-10-30
EP0296123A2 (en) 1988-12-21
HU204101B (en) 1991-11-28
PT87763A (pt) 1988-07-01
NZ225071A (en) 1991-05-28
US5116816A (en) 1992-05-26
ATE110784T1 (de) 1994-09-15
JPS6425798A (en) 1989-01-27
CA1338183C (en) 1996-03-26
MY103735A (en) 1993-09-30
AU1812488A (en) 1988-12-22
ES2056954T3 (es) 1994-10-16
DE3851268D1 (de) 1994-10-06
AU623078B2 (en) 1992-05-07
HUT50220A (en) 1989-12-28
FI87928B (fi) 1992-11-30
FI882926A (fi) 1988-12-20
EP0296123A3 (en) 1990-06-20
FI87928C (fi) 1993-03-10
EP0296123B1 (en) 1994-08-31
DE3851268T2 (de) 1995-01-26
JP2641256B2 (ja) 1997-08-13
KR890000518A (ko) 1989-03-15
IL86789A (en) 1993-02-21
IL86789A0 (en) 1988-11-30
IE64008B1 (en) 1995-06-28
IE881838L (en) 1988-12-19
KR970010928B1 (ko) 1997-07-02

Similar Documents

Publication Publication Date Title
ATE110784T1 (de) Zyklische peptolide.
AU588860B2 (en) Improvements in or relating to organic compounds
CA2154170A1 (en) Cyclic imide thione activated polyalkylene oxides
CA2194533A1 (en) Light-curing composite material
DK491986A (da) Retningsmikrofon
LU90842I2 (fr) Mabcampath-alemtuzumab et ses d-riv-s pharmaceutiquement acceptables
IT1254515B (it) Tassani di interesse oncologico, loro metodo di preparazione ed uso
ES2110009T3 (es) Derivados de la estreptolisina o.
CA2010739A1 (en) Bipolar voltage to frequency converter
IT8921553A0 (it) Convertitore di segnali elettrici analogici sbilanciati in segnali tutto differenziali.
FR2350397A1 (fr) Bouillon de culture indiquant la presence de levure candida et autres champignons
ES2099274T3 (es) Derivados de estreptolisina o.
FR2603302B1 (fr) Nouvelles souches de bacillus brevis et leur application
DK335288A (da) Peptolidderivater og fremgangsmaade til fremstilling deraf
NL350033I2 (nl) Gefuseerde middelen voor biologische controle
EA199900718A1 (ru) Новые соединения
ES2066422T3 (es) Expresion de un arn multigenes con actividad de autoempalme.
TR200000683T2 (tr) Bir araç koltuğu mesnet çerçeve yapısı için körük.
ES2028304T3 (es) Acelerometro ionicamente conductor.
SU586236A1 (ru) Сва
UA11791A1 (uk) Підсилювач
ES1034766U (es) Un pararrayos.
DE3673992D1 (de) Schaltungsanordnung mit einem am eingang einpolig angeschlossenen vierpol und einem verstaerker zur kompensation eines bezugspotentials.
ATE57978T1 (de) Dachziegel-wandanschluss-konstruktion.

Legal Events

Date Code Title Description
PC Transfer of assignment of patent

Owner name: NOVARTIS AG

FG Patent granted

Owner name: NOVARTIS AG